U.S. Bancorp has delivered a very strong 91.5% share price gain over the past three years, yet several valuation checks still point to the stock trading below an estimate of its intrinsic value. For investors, the focus is on how that gap between the market price and the Excess Returns model compares with a more mixed overall value score.
The 91.5% three year return suggests U.S. Bancorp has already rewarded patient shareholders. Any valuation upside now may matter more to new buyers than to those who held through the move.
Plans to expand business banking across faster growing U.S. states can support expectations for future earnings. The risk is that the cost and execution of this build out could weigh on profitability if revenue does not scale as hoped.
The stock earns a mixed valuation read, with a value score of 4 that points to some signs of undervaluation, but not a clear, across the board bargain.
The issue now is whether U.S. Bancorp's current share price already reflects these growth plans, or if the intrinsic value estimate and market multiples still leave a reasonable margin between price and value.
Seize the momentum around U.S. Bancorp's valuation gap and compare it with a curated list of other potential value opportunities using 50 high quality undervalued stocks .
Is U.S. Bancorp Still Cheap on Excess Returns?
The Excess Returns model for U.S. Bancorp starts with what shareholders earn on equity compared with the cost of that equity. On this view, the stock has an estimated intrinsic value of $101.50 per share, which implies the current price screens about 39.7% below that level.
The model uses a book value of $38.92 per share and a stable book value estimate of $42.64 per share, alongside a stable EPS estimate of $5.73 per share. With an average return on equity of 13.43% and a cost of equity of $3.32 per share, it arrives at an excess return of $2.41 per share that is capitalised into the intrinsic value. The recent decision by U.S. Bancorp to expand business banking across Florida, Georgia, Texas and Arizona helps explain why the market is weighing future growth against execution risk, even though the Excess Returns model still points to a sizeable discount.
On this Excess Returns view, U.S. Bancorp stock currently appears undervalued relative to its estimated intrinsic value.
Our Excess Returns analysis suggests U.S. Bancorp is undervalued by 39.7%. Track this in your watchlist or portfolio , or discover 50 more high quality undervalued stocks .
Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for U.S. Bancorp.
Is U.S. Bancorp Still Cheap on Earnings?
The P/E multiple suits a bank like U.S. Bancorp because earnings are a key driver of shareholder returns over time. On this measure, the stock trades on a P/E of 12.2x, which is slightly above the broader Banks industry average of 11.7x but below the peer group average of 15.2x.
The fair P/E ratio for U.S. Bancorp is estimated at 14.2x, based on its earnings profile, size and risk characteristics. That leaves the current 12.2x multiple at a discount to what this framework suggests, even though it is not the cheapest stock in the sector on raw industry comparisons alone. For investors weighing the recent business banking expansion against valuation, the P/E gap indicates that the market may not be fully reflecting the earnings power suggested by this model.
On the P/E test, U.S. Bancorp stock appears undervalued relative to the multiple implied by its fundamentals and peer group.
See what the numbers say about this price — find out in our valuation breakdown.
The U.S. Bancorp Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where this U.S. Bancorp valuation puzzle leaves off by spelling out the growth, margin and earnings paths that would need to play out for the stock to be worth materially more or less than today's price on the market. Rather than focus on a single multiple or model output, each narrative lays out the assumptions behind its view of fair value so you can compare those with U.S. Bancorp's actual results over time on the Community page.
The community is split on U.S. Bancorp, with one scenario leaning into digital and fee growth and the other questioning how much of that story is already in the price.
Bull case: 13% undervalued
"Continued investments in digital banking platforms and artificial intelligence are enabling durable operating efficiencies, expense control, and the potential for higher net margins..."
Read the full Bull Case to see why U.S. Bancorp could be undervalued
Bear case: 5% overvalued
"Outsourcing backend brokerage ops to Fidelity likely reduces in-house labor, IT maintenance, and network/security costs, though the main focus is on better capabilities rather than deep cost-cutting..."
Read the full Bear Case to see why U.S. Bancorp could be overvalued
Do you think there's more to the story for U.S. Bancorp? Head over to our Community to see what others are saying!
The Bottom Line
For U.S. Bancorp, both the Excess Returns intrinsic value estimate and the P/E comparison point in the same direction and suggest the stock still screens as undervalued rather than obviously fully priced. The mixed overall value score tempers that signal and flags that not every check lines up as a clear bargain. What really decides it from here is whether the business banking expansion and broader earnings profile can justify a stronger earnings path without eroding returns on equity. The key question for investors is whether the current discount reflects opportunity or fairly prices the execution risk around those growth plans.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any